Whether women are more susceptible than men to smoking-related lung cancer has been a topic of controversy. To address this question, we compared risks of lung cancer associated with smoking by sex. Altogether, 585,583 participants from 3 Norwegian cohorts (Norwegian Counties Study, 40 Years Study, and Cohort of Norway (CONOR) Study) were followed until December 31, 2013, through linkage of data to national registries. We used Cox proportional hazards models and 95% confidence intervals to estimate risks. During nearly 12 million person-years of follow-up, 6,534 participants (43% women) were diagnosed with lung cancer. More men than women were heavier smokers. Compared with never smokers, male and female current smokers with ≥16 pack-years of smoking had hazard ratios for lung cancer of 27.24 (95% confidence interval (CI): 22.42, 33.09) and 23.90 (95% CI: 20.57, 27.76), respectively (P for heterogeneity = 0.30). In contrast, for current smokers, in a model with pack-years measured continuously, men had a hazard ratio of 1.43 (95% CI: 1.39, 1.48) and women a hazard ratio of 1.64 (95% CI: 1.57, 1.71) for each 10-pack-year increment of smoking (P for heterogeneity < 0.01). Our results suggest that women have an increased susceptibility to lung cancer compared with men, given the same lifetime smoking exposure. cohort studies; Cohort of Norway (CONOR) Study; histology; lung neoplasms; sex differences; smoking Abbreviations: BMI, body mass index; CI, confidence interval; CONOR, Cohort of Norway.
Health Screening Surveys conducted by the Norwegian National Health Screening Service (now included in the Norwegian Institute of Public Health): the Norwegian Counties Study, the 40 Years Study, and the Cohort of Norway (CONOR) Study.
The Norwegian Counties Study took place between 1974 and 1978. Everyone aged 35-49 years and a 10% random sample of persons aged 20-34 years residing in 3 rural Norwegian counties (Finnmark, Sogn og Fjordane, and Oppland) were invited to undergo regular screening examinations for cardiovascular disease. The participation rate was 88% (14) (15) (16) .
In the 40 Years Study, men and women aged 40-42 years from all counties in Norway were invited to participate in a health survey during [1985] [1986] [1987] [1988] [1989] [1990] [1991] [1992] [1993] [1994] [1995] [1996] [1997] [1998] [1999] . In some counties, broader age groups were invited. These surveys included 420,000 Norwegians. The participation rate was 69% (17, 18) .
The CONOR Study consisted of 10 surveys (Tromsø Health Study IV, the second Nord-Trøndelag Health Study, the Hordaland Health Study, Oslo Study II, the Oslo Health Study, the Oppland and Hedmark Health Study, Tromsø Health Study V, the Oslo Immigrant Health Study, the Troms and Finnmark Health Study, and the second Romsås in Motion Study) from different regions in Norway, including different age groups ranging from 20 years to 103 years. These surveys were conducted in 1994-2003. The overall participation rate for the CONOR Study was 58% (14, 19, 20) .
In all of the studies, participants completed a baseline questionnaire including detailed assessments of smoking habits and other lifestyle factors. Height and weight were measured at the screening facility by trained nurses and were used to calculate body mass index (BMI; weight in kilograms divided by squared height in meters). We excluded participants who emigrated or died before the start of follow-up (n = 647), those with prevalent cancer (n = 11,321), and those with missing information on vital status (n = 190), measures of smoking exposure (n = 6,303), or any of the covariates (BMI, education, and physical activity; n = 31,796). Altogether, 50,257 participants were excluded, leaving 585,583 persons (52% women) in the analytical cohort.
The present study was approved by the Regional Committee for Medical Research Ethics South-East, Norway, and the National Data Inspectorate. More details about our study population may be found elsewhere (21) (22) (23) .
Exposure information
Information on current and former daily smoking, duration of smoking (in years), and number of cigarettes smoked per day was collected from the questionnaires. Former smokers were also asked about amount of time (years and/or months) since quitting. Only the CONOR Study asked participants about age at smoking initiation. In the other studies, we calculated this variable for both current (age at enrollment minus years of smoking) and former (age at enrollment minus years since quitting and duration of smoking) smokers.
Among the 367,046 ever smokers, the proportion of missing values was <2% for quantity smoked (cigarettes/day) (n = 6,552), <1% for smoking duration (n = 3,051), <3% for packyears of smoking (i.e., number of cigarettes smoked per day divided by 20, multiplied by smoking duration in years) (n = 8,280), and 21.6% for age at smoking initiation (n = 79,226).
In addition, 56% (n = 77,323) of the former smokers had missing values for years since quitting smoking and age at smoking initiation.
We categorized ever smokers according to age at smoking initiation (<16, 16-20, or ≥21 years), number of cigarettes smoked per day (1-10, 11-20, or >20), smoking duration (1-9, 10-19, 20-29, or ≥30 years), and pack-years of smoking (1-5, 6-15, or ≥16) . Former smokers were categorized by time since smoking cessation (0-4, 5-9, or ≥10 years). We adjusted for physical activity level at study enrollment (sedentary (reading, television-watching, and other seated activity), moderate (walking, bicycling, and/or similar activities for ≥4 hours/week), or heavy (light sports or heavy gardening for ≥4 hours/week, heavy exercise, or daily competitive sports)) and BMI at study enrollment. We merged group 1 (BMI <18.5) and group 2 (BMI 18.5-24.9) in the World Health Organization's BMI classification and retained group 3 (BMI ≥25.0) and group 4 (BMI ≥30.0) (24) . We used the most recent information regarding duration of education obtained from Statistics Norway to classify subjects into 3 education categories: <10, 10-12, and ≥13 years of education.
Follow-up and endpoints
We used the unique 11-digit personal identification number assigned to all residents of Norway to follow all participants for 1) cancer (through linkage to the Cancer Registry of Norway) and 2) emigration or death (through linkage to the Central Population Register). These national registries are both accurate and virtually complete (25) . Person-years were calculated from age at enrollment to age at lung cancer diagnosis, any incident cancer diagnosis (except basal cell carcinoma), emigration, death, or the end of follow-up (December 31, 2013), whichever occurred first.
Cancer sites were identified by the anatomical sites and histological codes in the International Classification of Diseases for Oncology (26) . All primary incident carcinomas of the trachea, bronchus, and lung (International Classification of Diseases, Seventh Revision, code 162 or corresponding codes from the International Classification of Diseases, Ninth Revision, or the International Classification of Diseases, Tenth Revision) were considered. Lung cancers were classified into 6 histological subtypes (squamous cell carcinoma, adenocarcinoma, large-cell carcinoma, other not specified non-small-cell carcinoma, small-cell carcinoma, and other carcinoma) according to the World Health Organization's International Histological Classification (26) . We present results on the risk of lung cancer overall and separately on risks of adenocarcinoma, squamous cell carcinoma, and small-cell carcinoma, which were the most frequent histological subtypes of lung cancer.
Statistical analysis
We calculated the age-standardized (2000 projected US population (27) ) incidence rate of overall lung cancer by sex and smoking status. All analyses were sex-specific unless otherwise noted.
We used a Cox proportional hazards model with attained age as the underlying time scale to estimate multivariate-adjusted hazard ratios and 95% confidence intervals for the associations between different measures of smoking exposure and the risk of lung cancer, overall and by histological subtype. We stratified the Cox models by cohort study and birth cohort (≤1950 and >1950) to overcome the heterogeneity for these variables. The a priori-selected covariates included in the final models were: physical activity level (sedentary, moderate, or heavy), BMI (24) , and duration of education (<10, 10-12, or ≥13 years), all measured at enrollment. Never smokers were used as the reference group in all categorical smoking analyses, except for the association between years since cessation and lung cancer risk, where we used current smokers as the reference group.
For former, current, and ever smokers, we estimated doseresponse associations between lung cancer (overall) and the following continuous variables: smoking duration in 10-year increments, tens of cigarettes smoked per day, tens of packyears, and age at smoking initiation. We evaluated the association between each 10-year increment of time since smoking cessation and lung cancer risk for former smokers only. In contrast to the categorical analyses, never smokers were excluded from the continuous analyses.
We used fractional polynomials to determine the function of the different smoking exposures that best fitted the data (28) . We entered the continuous variables into the multivariate Cox regression models via a set of defined transformations (x − 2, x − 1, x − 0.5, x0.5, x1, x2, x3, and log(x)), allowing for a maximum of 2 terms in the model. We found, as a result of these analyses, that the log-transformed model best fitted our data. We then compared the log-transformed effect of each smoking exposure for men and women and found similar sex differences.
We tested for trend across categories of measures of smoking for ever smokers based on the median values in each category, with the lowest category of each smoking exposure used as the reference group. We used the Wald test to test for heterogeneity by sex for the measures of smoking exposure and the risk of lung cancer.
We tested and found that the criteria for the proportional hazards assumption were met using Schoenfeld residuals (data not shown).
We performed similar analyses after excluding participants who were diagnosed with lung cancer within 2 years of enrollment. Possible interactions between smoking status and education (3 categories), BMI (3 categories), and physical activity (3 categories) were assessed. When we analyzed small-cell carcinomas, we collapsed men and women due to the small number of cases among never smokers.
We performed the analyses using STATA, version 14.0 (StataCorp LP, College Station, Texas). Two-sided P values less than 0.05 were considered statistically significant.
RESULTS
At enrollment, the proportions of never, former, and current smokers were 34%, 26%, and 40% in men and 41%, 21%, and 38% in women. During nearly 12 million person-years of follow-up, 6,534 participants (43% women) were diagnosed with lung cancer. For men, the age-standardized incidence rates of lung cancer among never, former, and current smokers were 9.2 per 100,000 person-years, 61.3 per 100,000 personyears, and 275.2 per 100,000 person-years, respectively. For women, the corresponding numbers were 17.6, 42.2, and 207.7, respectively. Adenocarcinomas were the most common tumor type for both sexes (33% in men and 41% in women). During follow-up, 14% of men and 9% of women died (from all causes). Table 1 shows that in the Norwegian Counties Study, 51% of men and 40% of women were current smokers at enrollment. In the most recent CONOR Study, these numbers were 31% for men and 32% for women. Stratified by birth cohort, 43% of men and 37% of women born in or before 1950 were current smokers. For those born after 1950, 37% of men and 39% of women were current smokers. Altogether, 18% of men and 8% of women had smoked for 30 years or more. Thirtytwo percent of men and 45% of women had started to smoke after age 20 years. Age at enrollment increased from the earliest study (the Norwegian Counties Study) to the most recent study (CONOR), while years of follow-up decreased for both sexes (data not shown). The mean age at lung cancer diagnosis was 64 years for men and 63 years for women (see Web  Table 1 , available at https://academic.oup.com/aje). Table 2 shows that the overall incidence rates of lung cancer for men in the Norwegian Counties Study, the 40 Years Study, and the CONOR Study were 102.4 per 100,000 person-years, 50.4 per 100,000 person-years, and 83.2 per 100,000 personyears, respectively. Corresponding incidence rates for women were 59.4, 42.0, and 51.5, respectively. Table 3 shows that in comparison with their never-smoker counterparts, both men (hazard ratio = 19.12, 95% confidence interval (CI): 15.78, 23.18) and women (hazard ratio = 13.63, 95% CI: 11.83, 15.70) who were current smokers at baseline had significantly increased risks of lung cancer overall. In both sexes, former smoking and current smoking showed significant associations with lung cancer risk for smoking duration, number of cigarettes smoked daily, pack-years of smoking, and age at smoking initiation (all P's for trend < 0.01). The heterogeneity test for both former and current smokers and overall lung cancer risk showed that these associations were stronger for men than for women (both P's for heterogeneity = 0.01). Table 3 shows that, compared with never smokers, male current smokers with ≥16 pack-years of smoking had a hazard ratio for lung cancer of 27.24 (95% CI: 22.42, 33.09), and female current smokers had a hazard ratio of 23.90 (95% CI: 20.57, 27.76) (P for heterogeneity = 0.30). Table 3 further shows that, for current smokers, the test for heterogeneity by sex for each variable category compared with never smokers was statistically significant for duration of smoking (all P's for heterogeneity < 0.05) but was not significant for the upper category (≥30 years of smoking) or for the other variables (number of cigarettes smoked per day, age at smoking initiation, and pack-years (except for the lowest category (1-5 pack-years))). Additionally, for former smokers, the test for heterogeneity by sex was not significant for any of the smoking variables.
For current smokers, the increase in lung cancer risk was significantly greater in women than in men when we examined the various measures of smoking exposure as continuous variables; for each 10-pack-year increment, the hazard ratio was 1.43 (95% CI: 1.39, 1.48) in men and 1.64 (95% CI: 1.57, 1.71) in women (P for heterogeneity < 0.01) ( Table 3 ). The test for heterogeneity was significant for increments (as (8) 42 (7) 45 (10) 42 (8) 42 (7) 43 (8) 44 (10) Person continuous measures) of 10 years of smoking duration and 10 cigarettes/day, with a higher risk for women who were current smokers than for men (both P's for heterogeneity < 0.01). When we examined the various measures of smoking exposure as continuous variables in former smokers, the heterogeneity test was significant by sex for 10 pack-years, with a higher increased risk of lung cancer per increment for women compared with men (P for heterogeneity < 0.01).
For ever smokers, the increase in risk of lung cancer overall differed significantly by sex, with a greater increased risk in women for increments of 10 years of smoking, 10 cigarettes/day, and 10 pack-years (all P's for heterogeneity < 0.01) ( Table 4) . We observed similar significant differences by sex for squamous cell carcinoma. For adenocarcinoma, we observed significant differences for increments of 10 cigarettes/day and 10 pack-years (Table 4 ). The log-transformed models in ever smokers and by cell type showed similar differences by sex (data not shown). Due to few cases of small-cell carcinoma, especially among never smokers, we did not stratify by sex when we examined this subtype. We found a significant dose-response association between smoking duration and risk of small-cell carcinoma (results not shown).
Of the interactions tested, neither BMI nor physical activity nor education was statistically significant for any of the outcomes investigated (data not shown).
The overall results stayed materially the same when we excluded subjects with lung cancer diagnosed within 2 years of enrollment (data not shown).
Web Table 2 shows that for male current smokers, the overall lung cancer risk differed significantly between the 40 Years Study and the CONOR Study, with a greater risk in the more recent study (CONOR). For female current smokers, the risks of lung cancer differed significantly between all 3 studies, with the highest risk being seen in the earliest study (the Norwegian Counties Study).
Web Table 3 shows that male current smokers born in or before 1950 had a hazard ratio of 23.11 (95% CI: 18.30, 29.20) , and the corresponding hazard ratio for men born after 1950 was 10.75 (95% CI: 7.62, 15.16) (P for heterogeneity < 0.01). Among women, the risk of lung cancer was greatest in the older birth cohort (born ≤1950) as well.
DISCUSSION
In this large prospective study, we found that compared with women, more men were ever and heavier smokers. More female than male never smokers were diagnosed with lung cancer during follow-up. The age-standardized incidence rate of lung cancer in men was more than 6-fold greater among former smokers and 30-fold greater among current smokers, compared with never smokers. The corresponding rates for lung cancer in women were more than doubled in former smokers and more than 10-fold greater in current smokers, compared with never smokers.
When we analyzed smoking exposure according to categorical groups (smoking status), we did not detect a difference between men and women. However, when we analyzed smoking exposure as a continuous variable, female current smokers had a significantly higher risk of lung cancer than male current smokers for increments of pack-years, cigarettes per day, and smoking duration. The pattern of a greater risk of lung cancer for women compared with men remained after exclusion of subjects diagnosed with lung cancer within the first 2 years after enrollment.
Five cohort studies published between 2004 and 2015, including 470-17,670 lung cancer cases, did not find a sex difference in susceptibility to the carcinogenic effects of cigarette smoke (8, 9, 11, 12, 29) . These cohort studies analyzed the risk of lung cancer according to fixed categories of smoking exposure. Our results are in accordance with theirs when we analyze the data this way. The increased risk of lung cancer among women that we found when we analyzed the data continuously is most likely concealed when the smoking exposure data are categorized. Since men are heavier smokers than women, within each category they are likely to be more heavily exposed than female smokers. Furthermore, the reference group for women comprises more lung cancer cases than that for men. This will also inflate the lung cancer risk for male smokers and attenuate that for women. The higher incidence rates of lung cancer for female never smokers compared with male never smokers is probably explained by more women than men being exposed to passive smoking. This is also what was found in a recent review (30) .
In Norway, men in every age group have a higher rate of death from cardiovascular disease than women (31); this was also found in the current study and could support the explanation for our finding of a sex difference in risk of lung cancer. A recent study from the European Prospective Investigation Into Cancer and Nutrition revealed lower relative risks of lung cancer in female current smokers than in male current smokers (32) . However, this could be explained by a much heavier smoking burden among men compared with women in countries included in the European Prospective Investigation Into Cancer and Nutrition, such as Italy, Spain, and Greece (32).
Our results suggesting lower relative risks of lung cancer in the most recent birth cohorts are not in accordance with findings observed in the United States (11) and the United Kingdom (33) , respectively, where changes were towards higher relative risks. The difference observed by birth cohort between our study and the US study is mainly due to the fact that we stratified birth cohorts by the year 1950 (in or before 1950 or after 1950), while the 2 most recent time periods (1982-1988 and 2000-2010) Table continues from the US study were closer in time and had shorter durations of follow-up (6-10 years). Likewise, a possible explanation for the change towards a lower relative risk in the most recent birth cohort in our study is that the proportion of lung cancer cases among persons under age 50 years is only 10% in Norway (2). Our study had several major strengths. It was based on a large, prospectively assembled Norwegian cohort comprising a high proportion of male and female ever smokers, with long, virtually complete follow-up due to the national registries in Norway. Another major strength is that the questions about duration of smoking (in years) and number of cigarettes smoked per day were open instead of presented with fixed categories. Moreover, we had more than 6,500 lung cancer cases, giving us more stable risk estimates and results that were less prone to chance. We were also able to examine the association between smoking and lung cancer according to histological subtype and according to different measures of smoking exposure.
A limitation of our study was the lack of updated information on smoking status during follow-up. In Norway, the proportion of daily smokers has decreased steadily, with a steeper reduction in men, and protection from passive smoking has increased, especially during the last decade of our follow-up period. This may explain some of the heterogeneity across birth cohorts and study cohorts. Because more men than women have quit smoking, this could explain some of the differences in lung cancer risk by sex that we found. We lacked information about passive smoking from the majority of the participants. Our reference group was therefore most likely contaminated with passive smokers. Since more men than women were smokers in our population, it is likely that more female never smokers than male never smokers were exposed to passive smoking. For women, this will have attenuated our observed risk of lung cancer among ever smokers; for men, it will have increased our observed risk of lung cancer among ever smokers. c Per 10-year increment for smoking duration, per 10 cigarettes/day for quantity smoked, per 10 pack-years for pack-years in former and current smokers, and per 10-year increment since smoking cessation in former smokers, for lung cancer overall.
d Pack-years were calculated as numbers of cigarettes smoked per day, divided by 20 and multiplied by smoking duration in years.
e Per year for age at smoking initiation in former and current smokers, for lung cancer overall. f For smoking cessation, current smokers were the reference group. Approximately 10% of the Norwegian population reported being occasional smokers during follow-up (34). Some of these occasional smokers may have been excluded from our analytical sample due to insufficient smoking information, whereas others may have been included in the reference group, together with women exposed to passive smoking. This misclassification would most likely have attenuated the revealed associations between smoking and lung cancer.
We also lacked information on possible confounders such as radon exposure and other exposures to air pollutants (1). We cannot rule out the possibility of residual confounding due to the above factors, or to other factors we did not measure.
In conclusion, our results suggest that women are more susceptible than men to lung cancer given the same smoking exposure. Efforts to eliminate smoking in both sexes should continue. c Per 10-year increment for smoking duration, per 10 cigarettes/day for quantity smoked, per 10 pack-years for pack-years among ever smokers, for lung cancer overall, adenocarcinoma, and squamous cell carcinoma.
e Per year for age at smoking initiation among ever smokers, for lung cancer overall, adenocarcinoma, and squamous cell carcinoma.
